Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

244.54
-6.5600-2.61%
Post-market: 244.540.00000.00%19:30 EDT
Volume:1.19M
Turnover:293.91M
Market Cap:15.87B
PE:16.72
High:250.64
Open:249.48
Low:244.49
Close:251.10
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.62
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.31
PE(LYR):-41.87

Loading ...

Jazz Pharmaceuticals Highlights Ziihera Launch, Targets $3-$5 Billion Zanidatamab Peak Sales Opportunity

Reuters
·
Aug 26

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX)

TIPRANKS
·
Aug 26

U.S. Research Roundup- Intuit, MongoDB, Zscaler

Reuters
·
Aug 26

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $281 from $264

THOMSON REUTERS
·
Aug 26

Jazz Pharma Says FDA Approves Ziihera Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

Reuters
·
Aug 25

Jazz Pharmaceuticals - Ziihera U.S. Prescribing Information Includes Boxed Warnings for Diarrhea and Embryo-Fetal Toxicity

THOMSON REUTERS
·
Aug 25

U.S. FDA Approves Ziihera® (Zanidatamab-Hrii) with and Without Tislelizumab Plus Chemotherapy in First-Line Her2+ Advanced Gastroesophageal Adenocarcinoma

THOMSON REUTERS
·
Aug 25

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Jazz Pharmaceuticals (JAZZ) As HER2 Pipeline Progress Fuels An Undervalued Narrative

Simply Wall St.
·
Aug 21

Jazz Pharmaceuticals Advances Phase 3 Xywav Dosing Study in Sleep Disorders

TIPRANKS
·
Aug 20

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Jazz Pharmaceuticals (JAZZ) Stock Looks Cheap On Earnings While Broader Checks Stay Mixed

Simply Wall St.
·
Aug 13

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

Jazz Pharmaceuticals is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 12

Jazz Pharmaceuticals' Actio Acquisition 'Makes Sense,' Has Good Synergy, RBC Says

MT Newswires Live
·
Aug 11

Jazz Pharmaceuticals price target raised to $283 from $280 at Morgan Stanley

TIPRANKS
·
Aug 11

Wells Fargo Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Aug 11

Jazz Pharmaceuticals Buys Actio Biosciences for at Least $820 Million

MT Newswires Live
·
Aug 10

Jazz Bets on Epilepsy Treatment with up to $1.32 Billion Deal for Actio

Reuters
·
Aug 10

Jazz Pharmaceuticals - to Buy Actio Biosciences for $820 Mln Upfront, up to $500 Mln Contingent

THOMSON REUTERS
·
Aug 10